4DX 4DMedical Ltd
- 0.595
- 0.0000.00%
4DMedical Ltd News
4DMedical Ltd Seeks Quotation for New Securities
4DMedical's Operating Revenue Grows 54% in Fiscal Q3
4DMedical's (ASX:4DX) operating revenue climbed 54% year on year on a proforma basis to AU$1.4 million for the third quarter of fiscal 2024, according to a Tuesday filing with the Australian bourse. Y
4DMedical Ltd Gears Up for New Share Quotation
4DMedical Ltd Expands Share Quotation
Here's Why We're Watching 4DMedical's (ASX:4DX) Cash Burn Situation
This ASX Healthcare Stock Is up 12% in 2 Days Since All Ords Inclusion: Should You Buy?
4DMedical Ltd (ASX: 4DX) shares are having another positive session.
4D Medical Price Target Cut 12% to A$1.10/Share by Bell Potter
4D Medical Price Target Cut 12% to A$1.10/Share by Bell Potter
4DMedical Narrows H1 FY24 Loss as Revenue Jumps 63%
4DMedical (ASX:4DX) reported Wednesday that it narrowed its loss per share in the six-month period ended Dec. 31, 2023, to AU$0.037 from the prior-year period's AU$0.051 loss per share. The medical te
4DMedical Secures Research Agreement With US Department of Veterans Affairs
Respiratory imaging technology company 4DMedical (ASX:4DX), through its wholly-owned subsidiary, Imbio, signed a research agreement with the US Department of Veterans Affairs' Center for Innovations i
4DMedical Signs Distribution Deal for Imbio Medical Imaging AI Services
4DMedical (ASX:4DX) signed a distribution agreement with Blackford Analysis for its Imbio medical imaging AI services. Blackford's platform serves as a medical imaging AI marketplace. Including Imbio'
4D Medical Price Target Cut 11% to A$1.25/Share by Bell Potter
4D Medical Price Target Cut 11% to A$1.25/Share by Bell Potter
4DMedical's Operating Revenue Soars 60% in Fiscal H1
4DMedical (ASX:4DX) 4DMedical said its operating revenue for the fiscal first half of 2024 ended Dec. 31 was AU$800,000, surging 60% from a year-ago period. The increase is attributable to a higher Sa
Why 4DMedical, A2 Milk, QBE, and Zip Shares Are Charging Higher Today
In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another decent gain. At the time of writing, the benchmark index is up 0.6% to 7,465.8 points.
4DMedical Enters Deal With Healthcare Company Philips to Expand XV Technology Commercialization; Shares Up 5%
Respiratory imaging technology company 4DMedical (ASX:4DX) signed a teaming agreement with healthcare company Philips for the commercialization expansion of XV Technology within the US Department of V
4DMedical Acquires Imbio
Medical technology firm 4DMedical (ASX:4DX) completed the acquisition of US-based medical technology company Imbio, according to a Monday release. With the acquisition, Imbio will expand 4DMedical's p
4DMedical and Imbio Merge to Create Comprehensive Cardiothoracic Image Analysis Portfolio
4DMedical and Imbio Merge to Create Comprehensive Cardiothoracic Image Analysis Portfolio
4DMedical Limited (ASX:4DX): Is Breakeven Near?
4D Medical Target Price Raised 27% to A$1.40/Share by Bell Potter>4DX.AU
4D Medical Target Price Raised 27% to A$1.40/Share by Bell Potter>4DX.AU
4DMedical Signs MoU to Expand Lung Ventilation Technology in the US
4DMedical (ASX:4DX) signed a memorandum of understanding with New York Stock Exchange-listed global healthcare firm Koninklijke Philips to investigate commercialization opportunities for the XV lung v
Australian Shares Flat Amid Expectations of Economic Growth Rut
Australian shares were flat with a negative bias on Wednesday as the country's economic growth is expected to remain in a rut well into 2024. The S&P/ASX 200 Index inched down 4.80 points to 7,073.60.
Analysis
Price Target
No Data
